• 0
Shop Products Free shipping over $900000
slider
slider
slider

Brands Fluoxetine

Fluoxetine Capsules, 10mg Strenght Antidepressant 1000 per Bottle

Product # : 72241-0007-11 Class : MDR Distributor : RELIANCE INC Category : Antidepressants 10 mg Strength Availability : To place an order for this exclusive item, please contact customer service at info@RxReliance.com

$0.00

⚠️ License required to purchase this product.
Volume
Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient
Volume

Product Specifications

Product No. # 72241-0007-11
Manufacturer # 372241007118
Brand Fluoxetine
Manufacturer Modavar
Country of Origin India
Application Antidepressant
Volume 6 Bottles/BX (1000/BT)
Container Type Bottle
Shipping Width 6.5
Shipping Height 9.73
Shipping Depth 6.5
Dimension UOM IC
Shipping Weight 4.1625
Weight UOM LB
Active Ingredients Antidepressant
Container Type Bottle
Dosage Form Capsule
QTY Per Sell 6000
Strength 10 mg Strength
Volume 6 Bottles/BX (1000/BT)
Simply Medical Category Antidepressants 10 mg Strength
Class MDR
Supply Manager Category Antidepressants 10 mg Strength
Supply Manager Hierarchy
Pharmaceuticals>Rx>Antidepressants>Antidepressant
California Prop 65 No
Legend Code Yes
Stock Status NonStock
FSA Eligible Yes
GTIN 20372241007112
Ready to Sell Ready to sell
Pureplay CoT Restriction No
Features
  • INDICATIONS & USAGE:
  • Fluoxetine capsules are indicated for the treatment of:
  • Acute and maintenance treatment of Major Depressive Disorder.
  • Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD).
  • Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa.
  • Acute treatment of Panic Disorder, with or without agoraphobia.
  • Fluoxetine capsules and Olanzapine in Combination is indicated for the treatment of:
  • Acute treatment of depressive episodes associated with Bipolar I Disorder.
  • Treatment Resistant Depression (Major Depressive Disorder in patient, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
  • Fluoxetine capsules monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression.
  • When using fluoxetine capsules and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax®.